Invention Grant
- Patent Title: Anti-cancer drug
- Patent Title (中): 抗癌药
-
Application No.: US12995942Application Date: 2009-04-28
-
Publication No.: US09226934B2Publication Date: 2016-01-05
- Inventor: Hideaki Tahara , Masahisa Jinushi
- Applicant: Hideaki Tahara , Masahisa Jinushi
- Applicant Address: JP Tokyo
- Assignee: THE UNIVERSITY OF TOKYO
- Current Assignee: THE UNIVERSITY OF TOKYO
- Current Assignee Address: JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: WOPCT/JP2008/001393 20080602
- International Application: PCT/JP2009/001940 WO 20090428
- International Announcement: WO2009/147781 WO 20091210
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; A61K31/7068 ; A61K31/337 ; A61K31/4164 ; A61K31/4745 ; A61K31/704 ; A61K31/7048 ; A61K33/24 ; A61K45/06 ; C07K16/18 ; C07K16/30 ; A61K39/00
Abstract:
The present invention is directed to an anti-cancer drug containing an anti-MFG-E8 antibody as an active ingredient, and to an anti-cancer drug which employs an anti-MFG-E8 antibody in combination with a cancer therapy employing an anti-cancer agent other than the anti-MFG-E8 antibody.
Public/Granted literature
- US20110081356A1 ANTI-CANCER DRUG Public/Granted day:2011-04-07
Information query
